ATE181361T1 - Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie - Google Patents
Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämieInfo
- Publication number
- ATE181361T1 ATE181361T1 AT95932544T AT95932544T ATE181361T1 AT E181361 T1 ATE181361 T1 AT E181361T1 AT 95932544 T AT95932544 T AT 95932544T AT 95932544 T AT95932544 T AT 95932544T AT E181361 T1 ATE181361 T1 AT E181361T1
- Authority
- AT
- Austria
- Prior art keywords
- sickle cell
- globin
- composition
- cell anemia
- treating sickle
- Prior art date
Links
- 230000002869 anti-sickling effect Effects 0.000 title abstract 2
- 229940124574 antisickling agent Drugs 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 208000007056 sickle cell anemia Diseases 0.000 title abstract 2
- 102100021519 Hemoglobin subunit beta Human genes 0.000 title 1
- 108091005904 Hemoglobin subunit beta Proteins 0.000 title 1
- 210000000267 erythroid cell Anatomy 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 102000018146 globin Human genes 0.000 abstract 1
- 108060003196 globin Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30879594A | 1994-09-19 | 1994-09-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE181361T1 true ATE181361T1 (de) | 1999-07-15 |
Family
ID=23195426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95932544T ATE181361T1 (de) | 1994-09-19 | 1995-09-19 | Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US5861488A (de) |
| EP (1) | EP0783575B1 (de) |
| JP (1) | JPH10509027A (de) |
| AT (1) | ATE181361T1 (de) |
| CA (1) | CA2199832C (de) |
| DE (1) | DE69510356D1 (de) |
| GR (1) | GR3031229T3 (de) |
| WO (1) | WO1996009385A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5853975A (en) | 1994-08-23 | 1998-12-29 | Millennium Pharmaceuticals, Inc. | Methods for identifying compositions for the treatment of body weight disorders, including obesity |
| WO1996009385A1 (en) * | 1994-09-19 | 1996-03-28 | Massachusetts Institute Of Technology | Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
| ES2348868T3 (es) | 2002-12-13 | 2010-12-16 | Genetix Pharmaceuticals Inc. | Vectores retrovirales terapeuticos para terapia genica. |
| WO2010012002A1 (en) * | 2008-07-25 | 2010-01-28 | Saryna Medical Corporation | Methods and systems for genetic analysis of fetal nucleated red blood cells |
| US8774488B2 (en) | 2010-03-11 | 2014-07-08 | Cellscape Corporation | Method and device for identification of nucleated red blood cells from a maternal blood sample |
| AU2011377617B2 (en) | 2011-09-23 | 2018-03-08 | Bluebird Bio, Inc. | Improved gene therapy methods |
| CA2850484C (en) | 2011-09-30 | 2021-01-26 | Bluebird Bio, Inc. | Compounds for improved viral transduction |
| GB201322798D0 (en) | 2013-12-20 | 2014-02-05 | Oxford Biomedica Ltd | Production system |
| WO2016039933A1 (en) | 2014-09-11 | 2016-03-17 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Lentiviral vector for treating hemoglobin disorders |
| WO2017059241A1 (en) | 2015-10-02 | 2017-04-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Lentiviral protein delivery system for rna-guided genome editing |
| KR20250134722A (ko) | 2016-02-12 | 2025-09-11 | 블루버드 바이오, 인코포레이티드. | Vcn 인핸서 조성물 및 이의 사용 방법 |
| CN108883136A (zh) | 2016-02-12 | 2018-11-23 | 蓝鸟生物公司 | Vcn增强子组合物及其使用方法 |
| US12110499B2 (en) | 2017-04-24 | 2024-10-08 | Seattle Children's Hospital | Homology directed repair compositions for the treatment of hemoglobinopathies |
| WO2021094752A1 (en) | 2019-11-12 | 2021-05-20 | Oxford Biomedica (Uk) Limited | Production system |
| EP4373951A1 (de) | 2021-07-19 | 2024-05-29 | 2seventy bio, Inc. | Vektorherstellungsverfahren |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0377676B1 (de) * | 1987-09-17 | 1995-05-24 | Massachusetts Institute Of Technology | Menschliche, erythroid-spezifische transkriptionsenhancer |
| US5239061A (en) * | 1990-06-20 | 1993-08-24 | Research Corporation Technologies, Inc. | Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin |
| US5631162A (en) * | 1993-06-11 | 1997-05-20 | Massachusetts Institute Of Technology | Retroviral vectors for transducing β-globin gene and β-locus control region derivatives |
| WO1995000657A1 (en) * | 1993-06-21 | 1995-01-05 | The Uab Research Foundation | Anti-sickling hemoglobin |
| WO1996009385A1 (en) * | 1994-09-19 | 1996-03-28 | Massachusetts Institute Of Technology | Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
-
1995
- 1995-09-19 WO PCT/US1995/011873 patent/WO1996009385A1/en not_active Ceased
- 1995-09-19 AT AT95932544T patent/ATE181361T1/de not_active IP Right Cessation
- 1995-09-19 CA CA002199832A patent/CA2199832C/en not_active Expired - Lifetime
- 1995-09-19 DE DE69510356T patent/DE69510356D1/de not_active Expired - Lifetime
- 1995-09-19 JP JP8511019A patent/JPH10509027A/ja active Pending
- 1995-09-19 EP EP95932544A patent/EP0783575B1/de not_active Expired - Lifetime
-
1997
- 1997-09-23 US US08/935,648 patent/US5861488A/en not_active Expired - Lifetime
-
1999
- 1999-01-19 US US09/234,009 patent/US6051402A/en not_active Expired - Lifetime
- 1999-09-16 GR GR990402320T patent/GR3031229T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2199832C (en) | 2000-08-01 |
| EP0783575A1 (de) | 1997-07-16 |
| CA2199832A1 (en) | 1996-03-28 |
| JPH10509027A (ja) | 1998-09-08 |
| US5861488A (en) | 1999-01-19 |
| WO1996009385A1 (en) | 1996-03-28 |
| US6051402A (en) | 2000-04-18 |
| EP0783575B1 (de) | 1999-06-16 |
| GR3031229T3 (en) | 1999-12-31 |
| DE69510356D1 (de) | 1999-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69510356D1 (de) | Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie | |
| DE59611371D1 (de) | Verfahren zur Herstellung von Erythropoietin frei von tierischen Proteinen | |
| ATE266723T1 (de) | Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen | |
| DE69430990D1 (de) | Zusammensetzung und methode zur anreicherung von weissen blutzellen aus menschlichem vollblut | |
| EA200100502A1 (ru) | СПОСОБЫ И КОМПОЗИЦИЯ ДЛЯ ВОССТАНОВЛЕНИЯ КОНФОРМАЦИОННОЙ СТАБИЛЬНОСТИ БЕЛКА СЕМЕЙСТВА p53 | |
| ATE257392T1 (de) | Verfahren zur modulierung der neovaskularisierung und/oder des wachstums von kollateraler arterien und / oder anderer arterien aus bestehenden arteriolären verbindungen | |
| NO963742L (no) | Fremgangsmåte til å stimulere hematopoese med hemaglobin | |
| DE69128893D1 (de) | Genetische veränderung von endothelzellen | |
| ATE209679T1 (de) | Proteine mit faktor viii aktivität, verfahren zu deren herstellung unter verwendung von genetisch modifizierten zellen und diese enthaltende zusammensetzungen | |
| DE69927507D1 (de) | Zusammensetzungen und verfahren zur behandlung von abnormaler zellvermehrung | |
| ATE342278T1 (de) | Verfahren zur behandlung von diabetes mittels kgf | |
| DE69837491D1 (de) | Menschliche mesenchymale stammzellen aus peripherem blut | |
| ATE59962T1 (de) | Thrombin bindender stoff und verfahren zu seiner herstellung. | |
| DE69939937D1 (de) | Translations-kontrollelemente für proteinexpression mit hoher ausbeute in den plastiden von höheren pflanzen und verfahren zu deren verwendung | |
| ZA87141B (en) | Dna sequences coding for proteins having the biological activity of husi-type i inhibitors,biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins | |
| ES2113878T3 (es) | Proteina c hibrida. | |
| ATE251886T1 (de) | Verwendunf von apoe zum binden von tau und map2c proteinen und zur behandlung von alzheimer's krankheit | |
| DE69940753D1 (de) | Verfahren zur Einführung von heterologischen Zellen in Fische | |
| DE69835813D1 (de) | Verfahren zur kultivierung von zellen und zur vermehrung von viren | |
| DE60102147D1 (de) | Anti-gefrier proteine, deren herstellung und verwendung | |
| DE19781038T1 (de) | Keratinozytenwachstumsfaktor-2-Produkte | |
| DE69529750D1 (de) | Verbesserungen in der herstellung von proteinen in wirtszellen | |
| ATE419348T1 (de) | Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten | |
| DE3485773D1 (de) | Aus kultivierten mesenchymzellen extrahierte makromolekuele zur behandlung von degenerationskrankheiten. | |
| UA10281C2 (uk) | Спосіб отримання речовини для лікування захворювань підшлункової залози |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |